DICHLOROACETONITRILE. 1. Exposure Data

Similar documents
DIBROMOACETONITRILE. 1. Exposure Data

GLYCIDALDEHYDE. 1. Exposure Data

1,4-BENZOQUINONE (para-quinone) 1. Exposure Data

1,3-PROPANE SULTONE. 1. Exposure Data

DIMETHYLCARBAMOYL CHLORIDE. 1. Exposure Data

(Z)-1-Chloro-2,3,3,3-tetrafluoropropene (2017)

Dichlorvos DICHLORVOS (025)

AZIRIDINE. 1. Exposure Data

MELAMINE. 1. Exposure Data

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

5.17 PENTHIOPYRAD (253)

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

HC RED NO Exposure Data H2N~NH-CH2-CH2-0H N02. (d) Solubilty: Soluble in water (0.28% w/w), ethanol and acetone

5.15 HEXYTHIAZOX (176)

MATERIAL SAFETY DATA SHEET

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

BENZYL ACETATE. 1. Exposure Data

METHYL ACRYLATE. 1. Exposure Data

5.24 TRIAZOLE FUNGICIDE METABOLITES

Table of Contents. 1. Occurrence/use Health Significance... 4 Recommendation... 5 Key Bibliography... 6

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Table 4.5 Genetic and related effects of DDT in non-human mammals in vitro

HYDROGEN PEROXIDE HUMAN HEALTH EFFECTS. CAS No.: EINECS No.: REPORT VERSION: Draft of 24 April 2001

ETHYL ACRYLATE. 1. Exposure Data

METHYL IODIDE. 1. Exposure Data

5.36 THIOPHANATE-METHYL (077)

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Cycloxydim CYCLOXYDIM (179)

TR-469 Toxicology and Carcinogenesis Studies of AZT (CAS No ) and AZT/-Interferon A/D B6C3F1 Mice (Gavage Studies)

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

GLYPHOSATE (addendum)

N,N -DIETHYLTHIOUREA. 1. Exposure Data. 1.1 Chemical and physical data Nomenclature

Summary of Toxicity Studies on Imazapyr

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL

MATERIAL SAFETY DATA SHEET

Genotoxicity Testing Strategies: application of the EFSA SC opinion to different legal frameworks in the food and feed area


ENVIRONMENTAL REGULATIONS AND STANDARD SETTING Health Based Standards: Oncology - Luc Hens

IMPURITIES: GUIDELINE FOR RESIDUAL SOLVENTS PDE FOR CUMENE

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Comparison of different genotoxicity tests in vitro for assessment of surface water quality E. Dopp, J. Richard, S. Zander-Hauck

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Risk Assessment Report on Tris (nonylphenyl)phosphite (TNPP)

Scientific Facts on. Water Disinfectants. & disinfectant by-products

Lecture -2- Environmental Biotechnology

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

International Agency for Research on Cancer (IARC) - Summaries & Evaluations

NITRILOTRIACETIC ACID AND ITS SALTS. 1. Exposure Data

Read-across illustrative example

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

TRIS(2,3-DIBROMOPROPYL) PHOSPHATE. 1. Exposure Data

CVMP assessment report regarding the request for an opinion under Article 30(3) of Regulation (EC) No. 726/2004

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE

Melamine (2016) Copyright OARS IV. ANIMAL TOXICITY DATA I. IDENTIFICATION (1,2)

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Glyphosate Hazard and Risk Assessment: A Comparison of the Approaches of Two International Agencies

SCIENTIFIC OPINION. EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) 2, 3

Opinion of the Scientific Panel on food additives, flavourings, processing aids and materials in contact with food (AFC) on a request related to

Genotoxicity of 2-Hydroxy-1,4-naphthoquinone (Lawsone, CAS )

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

CoCAM 2, April 2012 INITIAL TARGETED ASSESSMENT PROFILE

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Radiofrequency Radiation

Comments CLH proposal Cadmium hydroxide

SIAM 19, October 2004 SIDS INITIAL ASSESSMENT PROFILE SUMMARY CONCLUSIONS OF THE SIAR

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE

Genotoxicity of formaldehyde in vitro and in vivo. Günter Speit

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

CHLOROTHALONIL. 1. Exposure Data

Dithianon DITHIANON (180)

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE

SCIENTIFIC OPINION. EFSA Panel on food contact materials, enzymes, flavourings and processing aids (CEF) 2, 3

VICH GL23: Studies to evaluate the safety of residues of veterinary drugs in human food: genotoxicity testing

5.3 AZINPHOS METHYL (002)

Captan (Pesticides) Summary. Risk assessment report. Food Safety Commission of Japan. Conclusion in Brief

H 2 C CH 2 CH 2 CH 2 O 2 S O C 4 H 8 O 3 S. Classification/MAK value: see Section III A2) MAK List 1985 Classification/MAK value dates from: 1986

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Biomarkers of acrylamide

O-TOLUENESULFONAMIDE CAS N :

ALLYL CHLORIDE. 1. Exposure Data

DIMETHYLFORMAMIDE. 1. Exposure Data

European public MRL assessment report (EPMAR)

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

METHYL CHLORIDE. 1. Exposure Data

Antimicrobial AlphaSan Test Report Summary Table 08/21/01

Part 2. Chemical and physical aspects

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

To: Recipients of JACC 42. HV/mls/JACC 42 corrigendum Brussels, 15 December 2004

Genomic Instability Induced by Ionizing Radiation

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Transcription:

DICHLOROACETONITRILE Data were last evaluated in IARC (1991). 1. Exposure Data 1.1 Chemical and physical data 1.1.1 Nomenclature Chem. Abstr. Serv. Reg. No.: 3018-12-0 Chem. Abstr. Name: Dichloroacetonitrile 1.1.2 Structural and molecular formulae and relative molecular mass Cl Cl CH C N C 2 HNCl 2 Relative molecular mass: 109.94 1.1.3 Physical properties (for details, see IARC, 1991) (a) Boiling point: 112 113 C (b) Conversion factor: mg/m 3 = 4.5 ppm 1.2 Production and human exposure Halogenated acetonitriles are not produced on an industrial scale. Several halogenated acetonitriles have been detected in chlorinated drinking-water in a number of countries as a consequence of the reaction of chlorine with natural organic substances present in untreated water. The only known route of human exposure is through chlorinated drinking-water (IARC, 1991). 2. Studies of Cancer in Humans 1375

1376 IARC MONOGRAPHS VOLUME 71 3. Studies of Cancer in Experimental Animals Dichloroacetonitrile was tested in a limited carcinogenicity study in female SEN mice by skin application, in an initiation/promotion study in female SEN mice by skin application and in a screening assay for lung tumours in female strain A mice by oral administration. No skin tumour was produced after skin application in mice or in the initiation/promotion study, in which dichloroacetonitrile was applied topically as six equal doses over a two-week period, followed by repeated doses of 12-O-tetradecanoylphorbol 13-acetate for 20 weeks. There was no increase in either the proportion of mice with lung tumours or the number of lung tumours per mouse (IARC, 1991). 4. Other Data Relevant to an Evaluation of Carcinogenicity and its Mechanisms 4.1 Absorption, distribution, metabolism and excretion 4.1.1 Humans 4.1.2 Experimental systems Studies with [1-14 C]dichloroacetonitrile in rats and mice and [2-14 C]dichloroacetonitrile in rats indicated that the substance is rapidly absorbed after oral administration in water. Excretion of radioactivity following dosing with [1-14 C]dichloroacetonitrile is more rapid in mice than in rats. In mice, approximately 84% of the dose was excreted in 24 h (67% in urine, 11% in faeces, 5% as CO 2 ), compared with 67% in rats in six days (44% in urine, 17% in faeces, 6% as CO 2 ). Excretion of [2-14 C]dichloroacetonitrile radioactivity in rats accounted for about 84% of the dose within 48 h (38% in urine, 12% in faeces, 34% as CO 2 ). The quantitative differences in the route of excretion of the two labels in rats indicate that dichloroacetonitrile is being cleaved in vivo. The 1-14 C- labelled compound behaved like cyanide (IARC, 1991). 4.2 Toxic effects 4.2.1 Humans 4.2.2 Experimental systems Dichloroacetonitrile did not induce γ-glutamyltranspeptidase-positive foci in rat liver. An oral dose by gavage of 65 mg/kg bw per day for 90 days to male and female CD rats reduced body weights, spleen and gonad weights and serum cholesterol levels; other blood chemistry and haematological parameters were generally unchanged. Liver weights relative to body or brain weight were increased in female rats (IARC, 1991).

4.3 Reproductive and developmental effects 4.3.1 Humans DICHLOROACETONITRILE 1377 4.3.2 Experimental systems Dichloroacetonitrile given orally to rats at a dose of 45 mg/kg bw per day on gestation days 6 18 was associated in the full-term fetuses with an increased frequency of malformations of soft tissues, particularly of the cardiovascular and urogenital organs, and some skeletal malformations. This dose was also severely embryotoxic and toxic to the pregnant rats (IARC, 1991). 4.4 Genetic and related effects 4.4.1 Humans 4.4.2 Experimental systems (see Table 1 for references) Dichloroacetonitrile induced DNA damage and mutation in bacteria. Sex-linked recessive lethal mutations were induced in Drosophila melanogaster. It weakly induced sister chromatid exchanges and DNA strand breaks in mammalian cell lines. Micronuclei were induced in the erythrocytes of newt (Pleurodeles waltl) larvae exposed for 12 days, but in mice dosed for five days, neither micronuclei in bone marrow nor abnormal sperm morphology were induced. 5. Evaluation No epidemiological data relevant to the carcinogenicity of dichloroacetonitrile were available. There is inadequate evidence in experimental animals for the carcinogenicity of dichloroacetonitrile. Overall evaluation Dichloroacetonitrile is not classifiable as to its carcinogenicity to humans (Group 3). 6. References Bull, R.J., Meier, J.R., Robinson, M., Ringhand, H.P., Laurie, R.D. & Stober, J.A. (1985) Evaluation of mutagenic and carcinogenic properties of brominated and chlorinated acetonitriles: by-products of chlorination. Fundam. appl. Toxicol., 5, 1065 1074

Table 1. Genetic and related effects of dichloroacetonitrile Test system Result a Dose b (LED or HID) Reference Without exogenous metabolic system With exogenous metabolic system PRB, SOS chromotest, Escherichia coli PQ37 (+) 50 Le Curieux et al. (1995) SA0, Salmonella typhimurium TA100, reverse mutation + NT 250 Simmon et al. (1977) SA0, Salmonella typhimurium TA100, reverse mutation + + 88 Bull et al. (1985) SA0, Salmonella typhimurium TA100, reverse mutation + + 10 Le Curieux et al. (1995) (fluctuation test) SA5, Salmonella typhimurium TA1535, reverse mutation + + 11 Bull et al. (1985) SA7, Salmonella typhimurium TA1537, reverse mutation NG Bull et al. (1985) SA8, Salmonella typhimurium TA1538, reverse mutation NG Bull et al. (1985) SA9, Salmonella typhimurium TA98, reverse mutation + + 680 Bull et al. (1985) SCH, Saccharomyces cerevisiae, mitotic recombination NT NG Simmon et al. (1977) DMX, Drosophila melanogaster, sex-linked recessive lethal mutations + 200 ppm feed Valencia et al. (1985) SIC, Sister chromatid exchange, Chinese hamster ovary CHO cells (+) + 2.3 Bull et al. (1985) in vitro DIH, DNA strand breaks, human lymphoblastic cell line in vitro (+) NT NG Daniel et al. (1986) Micronucleus test, Pleurodeles waltl erythrocytes in vivo + 0.25 Le Curieux et al. (1995) MVM, Micronucleus test, CD-1 mouse bone-marrow cells in vivo 50 po 5 Bull et al. (1985) SPM, Sperm morphology, B6C3F 1 mice in vivo 50 po 5 Meier et al. (1985) 1378 IARC MONOGRAPHS VOLUME 71 a +, positive; (+), weak positive;, negative; NT, not tested b LED, lowest effective dose; HID, highest ineffective dose; in-vitro tests, μg/ml; in-vivo tests, mg/kg bw/day; NG, not given; po, oral

DICHLOROACETONITRILE 1379 Daniel, F.B., Schenck, K.M., Mattox, J.K., Lin, E.L.C., Haas, D.L. & Pereira, M.A. (1986) Genotoxic properties of haloacetonitriles: drinking water by-products of chlorine disinfection. Fundam. appl. Toxicol., 6, 447 453 IARC (1991) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 52, Chlorinated Drinking-Water; Chlorination By-Products; Some Other Halogenated Compounds; Cobalt and Cobalt Compounds, Lyon, pp. 269 296 Le Curieux, F., Giller, S., Gauthier, L., Erb, F. & Marzin, D. (1995) Study of the genotoxic activity of six halogenated acetonitriles, using the SOS chromotest, the Ames-fluctuation test and the newt micronucleus test. Mutat. Res., 341, 289 302 Meier, J.R., Bull, R.J., Stober, J.A. & Cimino, M.C. (1985) Evaluation of chemicals used for drinking water disinfection for production of chromosomal damage and sperm-head abnormalities in mice. Environ. Mutag., 7, 201 211 Simmon, V.F., Kauhanen, K. & Tardiff, R.G. (1977) Mutagenic chemicals identified in drinking water. In: Scott, D., Bridges, B.A. & Sobels, F.H., eds, Progress in Genetic Toxicology, Vol. 2, Development in Toxicology and Environmental Sciences, Amsterdam, Elsevier, pp. 249 258 Valencia, R., Mason, J.M., Woodruff, R.C. & Zimmering, S. (1985) Chemical mutagenesis testing in Drosophila. III. Results of 48 coded compounds tested for the National Toxicology Program. Environ. Mutag., 7, 325 348